肉瘤治疗的治疗策略:初步的临床证据
Luca Filippi1, Cristina Ferrari2, Giuseppe Rubini2
1Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
Expert opinion on investigational drugs
|October 5, 2024
概括
热诺斯提克在肉瘤治疗方面表现有前途. 纤维细胞激活蛋白 (FAP) 抑制剂提供有效的疾病控制与低毒性,而其他目标,如PSMA需要进一步研究的肉瘤治疗.
科学领域:
- 在瘤学瘤学.
- 核医学是一种核医学.
- 放射性药物疗法是一种放射性药物疗法.
背景情况:
- 瘤是各种癌症,对于晚期或耐火病例的治疗选择有限.
- 综合诊断和治疗的治疗学,为管理这些具有挑战性的恶性瘤提供了一种新的方法.
研究的目的:
- 审查在肉瘤中治疗术策略的初始临床应用.
- 评估瘤向生物标志物,包括纤维细胞激活蛋白 (FAP),前列腺特异性膜抗原 (PSMA),C-X-C化学因子受体4型 (CXCR4) 和体静止素受体2 (SSTR2).
主要方法:
- 审查目前关于肉瘤治疗治疗方法的文献.
- 对瘤患者的FAP,PSMA,CXCR4和SSTR2向药物的临床数据的分析.
主要成果:
- 向CXCR4的治疗药物显示异质的吸收和与免疫组织化学的差相关性.
- 针对SSTR2的方法仅限于单个案例.
- 在肉瘤患者中早期的FAP抑制剂试验显示出有希望的疾病控制和最小的毒性.
- 针对肉瘤的PSMA向治疗药物目前是事,需要进一步调查.
结论:
- FAP抑制剂显示出对瘤治疗的显著潜力,提供有效的疾病控制与低毒性.
- 进一步的临床试验至关重要,以验证基于FAPI和PSMA的治疗药物用于个性化的肉瘤治疗.
- 热诺斯蒂克在推进肉瘤治疗范式方面具有前景.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:27Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
01:21Cancer Survival Analysis
329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329